Lamotrigine Tablet, Extended Release
Product Images NDC 82804-105

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 82804-105). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Image Clinicalstudy1 Partialonsetseizure)

This text provides data on responder rate, improvement, and worsening for Lamotrigine Extended-Release Tablets compared to placebo based on the number of patients. The percentages of equal or greater improvement, worsening, and responses are listed.*

FDA Label Image

1 (Image Clinicalstudy2 Partialonsetseizure)

FDA Label Image

82804-105-30 (Label 50mg)

This text provides detailed information about Lamotrigine 50mg Extended-Release Tablets, including dosage instructions, product characteristics, manufacturer details, and storage recommendations. It also emphasizes the importance of dispensing the Medication Guide to each patient and keeping the medication out of the reach of children. The text includes relevant identification numbers and expiration dates for the product.*

FDA Label Image

Image (Logo mg)

FDA Label Image

Logo (Logo Pi)

FDA Label Image

1 (Structure)

FDA Label Image

Image (Tabletsappearence)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.